Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EBT (2016 - 2025)

INVO Fertility (IVF) has disclosed EBT for 15 consecutive years, with -$2.6 million as the latest value for Q3 2025.

  • On a quarterly basis, EBT fell 65.14% to -$2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$11.0 million, a 48.7% decrease, with the full-year FY2024 number at -$9.1 million, down 13.89% from a year prior.
  • EBT was -$2.6 million for Q3 2025 at INVO Fertility, down from $12.7 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $12.7 million in Q2 2025 to a low of -$17.4 million in Q1 2025.
  • A 5-year average of -$2.2 million and a median of -$2.5 million in 2021 define the central range for EBT.
  • Peak YoY movement for EBT: plummeted 2816.55% in 2022, then skyrocketed 665.76% in 2025.
  • INVO Fertility's EBT stood at $101782.0 in 2021, then tumbled by 2816.55% to -$2.8 million in 2022, then increased by 28.69% to -$2.0 million in 2023, then crashed by 86.51% to -$3.7 million in 2024, then grew by 28.09% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's EBT are -$2.6 million (Q3 2025), $12.7 million (Q2 2025), and -$17.4 million (Q1 2025).